01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $17.82B
YoY changeLargest recent move+43.7%in FY17Latest −0.1%
02—Ledger
Free Cash Flow, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $17.82B | −0.1% | 10-K | |
| FY2024 | $17.83B | −19.2% | 10-K | |
| FY2023 | $22.06B | −9.0% | 10-K | |
| FY2022 | $24.25B | +10.3% | 10-K | |
| FY2021 | $21.99B | +31.0% | 10-K | |
| FY2020 | $16.79B | +31.5% | 10-K | |
| FY2019 | $12.77B | −0.1% | 10-K | |
| FY2018 | $12.79B | +35.6% | 10-K | |
| FY2017 | $9.43B | +43.7% | 10-K | |
| FY2016 | $6.56B | −6.3% | 10-K | |
| FY2015 | $7.00B | +138.4% | 10-K | |
| FY2014 | $2.94B | −49.2% | 10-K | |
| FY2013 | $5.78B | −3.9% | 10-K | |
| FY2012 | $6.01B | +2.1% | 10-K | |
| FY2011 | $5.89B | — | 10-K |
03—Questions
What is AbbVie Inc.'s current free cash flow?
AbbVie Inc. (ABBV) annual free cash flow for 2025 was $17.82B, a 0.09% decline from 2024. AbbVie Inc. free cash flow for the quarter ending March 31, 2026 was $3.56B.
What was AbbVie Inc.'s free cash flow in 2024?
AbbVie Inc. annual free cash flow for 2024 was $17.83B, a 19.17% decline from 2023.
What was AbbVie Inc.'s free cash flow in 2023?
AbbVie Inc. annual free cash flow for 2023 was $22.06B, a 9.02% decline from 2022.
What is AbbVie Inc.'s 5-year free cash flow CAGR?
AbbVie Inc. free cash flow grew at a compound annual growth rate (CAGR) of 1.19% from FY2020 to FY2025, going from $16.79B to $17.82B over 5 years.
- Company
- AbbVie Inc.
- Ticker
- ABBV
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations